WEDGE Capital Management L »

BioCryst Pharmaceuticals shares owned by WEDGE Capital Management L

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by WEDGE Capital Management L from 13F filings

Historical chart of WEDGE Capital Management L investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by WEDGE Capital Management L consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by WEDGE Capital Management L

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.8M 381k 10.00

More positions owned by WEDGE Capital Management L

KLA-Tencor Corporation (KLAC)
Applied Materials (AMAT)
Lam Research (LRCX)
Amphenol Corporation (APH)
Alphabet Inc Class A cs (GOOGL)
Dell Technologies (DELL)
Dropbox Inc-class A (DBX)
Clear Secure (YOU)
Arista Networks (ANET)
Jabil Circuit (JBL)
Keysight Technologies (KEYS)
Curtiss-Wright (CW)
Texas Instruments Incorporated (TXN)
SYNNEX Corporation (SNX)
Ss&c Technologies Holding (SSNC)

View all positions for WEDGE Capital Management L

Top funds holding BioCryst Pharmaceuticals

BlackRock
RA Capital Management
Deerfield Management Company
State Street Corporation
Vanguard Portfolio Management
Vanguard Capital Management
TCG Crossover Management
Henderson Group
Perceptive Advisors
Vestal Point Capital
Two Sigma Investments
Geode Capital Management
Kynam Capital Management
Bank of America Corporation
Standard Life Aberdeen

View all funds holding BioCryst Pharmaceuticals